1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CATALYST PHARMACEUTICALS INC
Catalyst Pharmaceuticals Inc
XNAS: CPRX

Catalyst Pharma Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Com...

Read More
31.15 -0.01 (-0.03%)
Near 52W High of $32.56
4.5M
XNAS Volume

XNAS 08 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Delisting
Catalyst Pharmaceuticals rises on Thursday as it agrees to be taken private in a $4.1 billion deal See details
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Mid Valuation
42.5 / 100
Momentum Score
Technically Bullish
70.3 / 100
Momentum Trap These stocks have average financials but are currently seeing momentum. Investors should exercise caution in buying these stocks View Similar Embed DVM
Analyst Price Target
33
1Yr Price target upside is 7%
5 analysts

22

S

7

W

2

O

1

T

SWOT Analysis

Catalyst Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..